Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 February;53(1) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 February;53(1):72-7

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi

 

REVIEW  IMAGING INFLAMMATION-INFECTION-ATHEROSCLEROSIS WITH PET AND SPECT RADIOPHARMACEUTICALS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 February;53(1):72-7

Copyright © 2009 EDIZIONI MINERVA MEDICA

lingua: Inglese

Scintigraphic imaging in renal infections

Rossleigh M. A. 1, 2

1 Department of Nuclear Medicine Prince of Wales and Sydney Children’s Hospitals Sydney, Australia 2 School of Medicine, University of New South Wales Sydney, Australia


PDF


The scintigraphic imaging modality of choice in the evaluation of renal infections is renal cortical scintigraphy utilizing [99mTc]dimercaptosuccinic acid (DMSA). This technique is able to demonstrate upper tract involvement with infection and to assess for the presence of renal cortical scarring following a urinary tract infection (UTI). There are recent publications advocating its use to determine which patients need to proceed to further investigation with cystography. It is also being utilized in the evaluation of different treatment regimes used in patients with UTI. Fluorodeoxyglucose (FDG)-PET and leukocyte scanning have only a minor role in the diagnosis of renal infection. Their main application is in the diagnosis of renal cyst infections in patients with polycystic renal disease.

inizio pagina